Latest DRC News
- Details
In 2016, Yabing Chen, Ph.D., a University of Alabama at Birmingham professor of pathology and research scientist at the Birmingham VA Medical Center, received a prestigious VA Research Career Scientist Award that provided five years of salary.
- Details
W. Timothy Garvey, MD, Butterworth Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham, was chosen to receive the Master of the American Association of Clinical Endocrinology (AACE) award. The MACE award is the highest honor to be awarded by AACE, the country’s leading professional organization of clinical endocrinologists.
- Details
In this episode, Andrew Butler, Ph.D., dean, UAB School of Health Professions, sits with W. Timothy Garvey, M.D., the Butterworth Endowed Professor in Nutrition Sciences and director of the UAB Diabetes Research Center. The two discuss his 4+ decades of studying obesity, diabetes, and more. Dr. Garvey talks about his "complication-centered" path of study, changing how the world defined obesity, and he gives his best advice to those struggling with weight - advice that may surprise you.
- Details
Amy Goss, Ph.D., assistant professor in the University of Alabama at Birmingham’s Department of Nutrition Sciences, has received a $3 million R01 grant to implement a family-based diet intervention to treat fatty liver disease and obesity in adolescents.
- Details
For decades, Americans have fought a losing battle with obesity. Between 1960 and 2010, the prevalence of adult obesity in the United States nearly tripled, to 36 percent from 13 percent, according to the Centers for Disease Control and Prevention.
- Details
Editor's Note: The information published in this story is accurate at the time of publication. Always refer to uab.edu/uabunited for UAB's current guidelines and recommendations relating to COVID-19.
Media contacts: Jeff Hansen and Savannah Koplon
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
- Details
Take a look back at a critical conversation about diabetes with Dr. Anath Shalev and Dr. Fernando Ovalle during Novel Approaches to Diabetes.
- Details
Type 1 diabetes, or T1D, results from the autoimmune destruction of the insulin-producing cells of the pancreas. People with T1D require exogenous insulin and suffer swings in the levels of glucose in the blood that impact life expectancy and increase risks of cardiovascular disease, neuropathies and kidney failure.
- Details
Type 1 diabetes, or T1D, is an autoimmune disease in which the body’s immune cells — led by inflammatory macrophages — attack and destroy the beta cells of the pancreas that produce insulin.
- Details
A new study, published in Nutrition and Metabolism, from researchers with the University of Alabama at Birmingham’s Nutrition Obesity Research Center observed improvements in body composition, fat distribution and metabolic health in response to an eight-week, very low-carbohydrate diet.